不同中药汤剂治疗缺血性卒中疗效的网络Meta分析
结果显示血府逐瘀汤降低NIHSS评分最优,参芪通络汤提高Barthel指数最优,化痰通络汤改善日常生活活动能力最优;总体血府逐瘀汤在三项结局中综合排名第一,参芪通络汤次之。
要点
- 血府逐瘀汤在降低NIHSS评分方面排名第一。
- 参芪通络汤在提高Barthel指数方面排名第一。
- 化痰通络汤在改善ADL评分方面排名第一。
核心结论
- 血府逐瘀汤降低NIHSS评分最有效,参芪通络汤提高BI评分最有效,化痰通络汤改善ADL评分最有效。
- 总体血府逐瘀汤在三项结局指标中综合排名第一,参芪通络汤在两项结局指标中排名第二。
研究设计与样本
- 检索PubMed、Embase、Cochrane Library、Web of Science及中文数据库,截至2024年4月。
- 采用RoB 2工具进行质量评价,使用R4.3.1和STATA 15.0进行贝叶斯网络Meta分析。
主要发现
- 血府逐瘀汤在降低NIHSS评分方面最有效。
- 参芪通络汤在提高Barthel指数评分方面最有效。
- 化痰通络汤在改善日常生活活动能力(ADL)评分方面最有效。
- 总体血府逐瘀汤在三项结局指标中综合排名第一,参芪通络汤次之。
临床怎么用
- 对于缺血性卒中患者,可参考网络Meta分析排名选择中药汤剂,如降低神经功能缺损可选血府逐瘀汤。
- 提高日常生活能力可考虑参芪通络汤或化痰通络汤,但需结合患者个体情况辨证使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Currently, traditional Chinese medicine (TCM) and its combinations are widely used in the treatment and rehabilitation of patients with ischemic stroke. However, current studies should mainly focus on the therapeutic effects of traditional Chinese medicines alone. This paper will employ a network meta-analysis to compare the efficacy of different TCM decoctions in the treatment of patients with ischemic stroke. METHODS: Chinese and English databases including PubMed, Embase, Cochrane Library, and Web of Science were searched to collect randomized controlled trials of TCM decoctions in the treatment of patients with ischemic stroke (IS), with a search time frame until April 2024. A library of references was created using EndNote 21. Quality assessment was performed using the Version 2 of the Cochrane risk-of-bias tool for randomized trials (RoB 2). A Bayesian network meta-analysis of data was performed using R4.3.1 and STATA 15.0. RESULTS: A network meta-analysis was conducted on 119 randomized controlled trials including 12,137 IS patients. The following TCM decoctions were involved: Xinglou Chengqi Decoction (XLCQT), Shenqi Tongluo Decoction (SQTLF), Zhongfeng Jiuxian Decoction (ZFJXT), Yiqi Tongluo Decoction (YQTLT), Tongqiao Huoxue Tang (TQHXT), Tongluo Xifeng Decoction (TLXFT), Tongluo Fuzheng Decoction (TLFZT), Xuefu Zhuyu Decoction (XFZYT), Xiaoxuming Decoction (XXMT), Qufeng Xingxue Tongluo Formula (QFXXTLF), Banxia Baizhu Tianma Decoction (BXBZTMT), Buyang Huanwu Tang (BYHWT),Huatan Tongluo Decoction (HTTLT), Yiqi Huoxue Tongluo Decoction (YQHXTLT), Yiqi Huoxue Decoction (YQHXT), and Yiqi Huoxue Kaiqiao Prescription (YQHXKQP). Of them, XFZYT was most effective in reducing the NIHSS score; SQTLF was most effective in increasing the Barthel Index (BI) score; and HTTLT was most effective in improving activities of daily living (ADL). CONCLUSION: This network meta-analysis provided data on the relative efficacy of different TCM decoctions. Of them, XFZYT was most effective in reducing the NIHSS score; SQTLF was most effective in increasing the BI score; and HTTLT was most effective in improving the ADL score. At the same time, overall, XFZYT ranked first with its best efficacy regarding all the three outcome measures above, and SQTLF came second with its impact on two of the outcome measures.
引用
- Ning B, Zhu X, Wu X, et al. Efficacy of different traditional Chinese medicine decoctions in the treatment of ischemic stroke: a network meta-analysis. Front Pharmacol. 2024. PMID: 39555103. doi:10.3389/fphar.2024.1486458
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。